Method of Nucleic Acid Enrichment Using Site-Specific Nucleases Followed by Capture
US 11,473,124 In forceTerm ends Dec 12, 2039 · Medium confidence
20-year base term ends Dec 12, 2039
Why Medium: No fee event states this; the fee state is read from the payments the fee record holds.
Dec 12, 2019
Dec 12, 2039
Oct 18, 2022
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 12, 2019, when the earliest non-provisional application in its chain was filed (this one was filed Jun 11, 2021) | Dec 12, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee events in USPTO's record of this patent. A gap in the record, not evidence of lapse | In force | Medium confidence |
| Computed term end | The steps above, in order | Dec 12, 2039 | Medium confidence |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.